Viewing Study NCT01634893


Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2026-07-13 @ 6:14 PM
Study NCT ID: NCT01634893
Status: COMPLETED
Last Update Posted: 2016-03-25
First Post: 2012-07-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Oral Hydroxychloroquine Plus Oral Sorafenib to Treat Patients With Refractory or Relapsed Solid Tumors
Sponsor: The University of Texas Health Science Center at San Antonio
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Refractory or Relapsed Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Refractory or Relapsed Solid Tumors View